Founded in 2005, Biodesix discovers and commercializes cancer tests (diagnostics) that help patients and their doctors make more informed decisions about treatment based on a patient’s unique molecular profile. We’re advancing precision medicine by helping oncologists provide the right patient with the right treatment at the right time.